NIFTY  8,907.85  0.32%
  SENSEX  28,761.60  0.35%
 CURRENCY  Rs  66.93/$ 70.86/€, 83.36/£
  GOLD  29,241.00  -0.21%
  SILVER  42,757.00  -0.33%
  DAX  11,827.60  0.60%
  FTSE  7,299.86  -0.00%
  CAC  4,864.99  -0.04%
  HANG SENG  23,963.60  -0.76%
  NIKKEI  19,381.40  0.68%
  Shanghai Composite  3,253.33  0.23%
  DOW JONES  20,624.10  0.02%
  NASDAQ  5,838.58  0.41%
  S&P 500  2,351.16  0.17%
GOVT OFFICIAL - Govt To Sell 5% Stake In Bharat Electronics On Feb 22 GOVT OFFICIAL - Govt Aims To Raise About Rs 1,600 Cr From BEL Divestment

For Cipla, Affordability Is Key: YK Hamied

Video:

Play this video

January 29: Cipla Chairman Y.K. Hamied tells Mini Menon about the company’s transformation from a low-cost manufacturer to spearheading pharma innovation across geographies. He discusses how Cipla seeks to replicate the success of the affordable Triomune HIV drug in other areas, while describing the Cipla’s new business model and strategy as the Indian pharma sector changes.